<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Arthritis Res Ther</journal-id><journal-title>Arthritis Research &#x00026; Therapy</journal-title><issn pub-type="ppub">1478-6354</issn><issn pub-type="epub">1478-6362</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">ar1927</article-id><article-id pub-id-type="pmid">16563189</article-id><article-id pub-id-type="doi">10.1186/ar1927</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>IFNGR1 </italic>single nucleotide polymorphisms in rheumatoid arthritis</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Mattyasovszky</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I4">4</xref><email>mattyasovsky@med3.imed.uni-erlangen.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Skapenko</surname><given-names>Alla</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>skapenko@med3.imed.uni-erlangen.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Kalden</surname><given-names>Joachim R</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>kalden@med3.imed.uni-erlangen.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Lipsky</surname><given-names>Peter E</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>lispkyp@mail.nih.gov</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Schulze-Koops</surname><given-names>Hendrik</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>schulze-koops@med3.imed.uni-erlangen.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen, Germany</aff><aff id="I2"><label>2</label>Department of Internal Medicine III, University of Erlangen, Germany</aff><aff id="I3"><label>3</label>National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA</aff><aff id="I4"><label>4</label>Department of Trauma Surgery, University of Mainz, Germany</aff><pub-date pub-type="ppub"><year>2006</year></pub-date><pub-date pub-type="epub"><day>23</day><month>3</month><year>2006</year></pub-date><volume>8</volume><issue>3</issue><fpage>R63</fpage><lpage>R63</lpage><ext-link ext-link-type="uri" xlink:href="http://arthritis-research.com/content/8/3/R63"/><history><date date-type="received"><day>30</day><month>11</month><year>2005</year></date><date date-type="rev-request"><day>6</day><month>2</month><year>2006</year></date><date date-type="rev-recd"><day>13</day><month>2</month><year>2006</year></date><date date-type="accepted"><day>22</day><month>2</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Mattyasovszky et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Mattyasovszky et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Mattyasovszky Stefan mattyasovsky@med3.imed.uni-erlangen.de </dc:author><dc:title> IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>Arthritis Research &#x00026; Therapy 8(3): R63-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1478-6354(2006)8:3&#x0003c;R63&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1478-6354</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>On the basis of their biological function, potential genetic candidates for susceptibility to rheumatoid arthritis can be postulated. <italic>IFNGR1</italic>, encoding the ligand-binding chain of the receptor for interferon gamma, IFN&#x003b3;R1, is one such gene because interferon gamma is involved in the pathogenesis of the disease. In the coding sequence of <italic>IFNGR1</italic>, two nucleotide positions have been described to be polymorphic in the Japanese population. We therefore investigated the association of those two <italic>IFNGR1 </italic>single nucleotide polymorphisms with rheumatoid arthritis in a case-control study in a central European population. Surprisingly, however, neither position was polymorphic in the 364 individuals examined, indicating that <italic>IFNGR1 </italic>does not contribute to susceptibility to rheumatoid arthritis, at least in Caucasians.</p></abstract></article-meta></front><body><sec><title>Introduction</title><p>Many pathologic autoimmune responses are characterized by an imbalance in the T helper type (Th) 1/Th2 ratio in favor of the former [<xref ref-type="bibr" rid="B1">1</xref>]. As activated Th1 cells mediate their functions via their signature cytokine, interferon gamma (IFN&#x003b3;), the interferon gamma receptor (IFN&#x003b3;R) plays an important role in the pathogenesis of these diseases by transmitting IFN&#x003b3; signaling. The IFN&#x003b3;R consists of the ligand-binding chain IFN&#x003b3;R1 and the signal-transducing chain IFN&#x003b3;R2. Within the coding region of the <italic>IFGR1 </italic>gene [GeneBank accession number <ext-link ext-link-type="gen" xlink:href="NM_000416">NM_000416</ext-link>], two single nucleotide polymorphisms (SNPs) (40 C/T and 1,400 T/C) that result in the amino acid substitutions valine to methionine at position 14 (V467M) and leucine to proline at position 467 (L467P), respectively, have been identified in the Japanese population [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Th1 cells have been implicated in many aspects of the pathogenesis of rheumatoid arthritis (RA) [<xref ref-type="bibr" rid="B1">1</xref>]. Evidence suggests that both genetic and environmental factors contribute to the development of rheumatoid inflammation [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Elucidating the genetic basis of RA, however, is still one of the major challenges in modern rheumatology. The identification of RA susceptibility genes has been difficult because RA is a complex autoimmune disease that, unlike classic Mendelian traits causally related to highly penetrant rare mutations of single genes, appears to be caused by small individual effects of many poorly penetrant common alleles.</p><p>The association of the two <italic>IFNGR1 </italic>SNPs 40 C/T and 1,400 T/C with susceptibility to immune disorders mediated by an imbalance in the Th1/Th2 ratio has recently been demonstrated in Japanese cohorts; for example, in allergy [<xref ref-type="bibr" rid="B2">2</xref>] and in systemic lupus erythematosis [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Because of the potential importance of <italic>IFNGR1 </italic>SNPs in immunity in health and disease in people of all ethnic origins, these observations prompted us to perform a case-control association study to investigate the role of both <italic>IFNGR1 </italic>SNPs in susceptibility to RA, a Th1-mediated autoimmune disease, in a Caucasian population.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>One hundred and one patients with an established diagnosis of RA, according to the 1987 revised criteria of the American College of Rheumatology for the classification of the disease, were enrolled in the study. The 101 patients represented an ethnically homogeneous cohort of Caucasian RA patients. The median (range) age of the patients at time of the analysis was 63 years (17&#x02013;81 years), and 76% were female. A cohort of 171 healthy individuals matched on the basis of age, sex and origin were used as a healthy control group. All protocols and recruitment sites have been approved by the local institutional review boards, and all subjects were enrolled with informed written consent.</p><p>Genomic DNA was isolated from white blood cells using the AquaPure Genomic DNA isolation kit (BioRad Laboratories, Munich, Germany). Genotype analysis was performed by allele-specific PCR and verified by direct sequencing. PCR primer and probe sequences for the V14M SNP were 5' -AGTGGAGTGGCTACAAAGGTCCC-3' (forward primer) and 5' -CCCATCTCAGCCCTGCTCAC/T-3' (reverse primer). PCR primer and probe sequences for the L467P SNP were 5' -CATGTGCTAGTGGATCTACT/C-3' (forward primer) and 5' -AGTGGAGTGGCTACAAAGGTCCC-3' (reverse primer).</p></sec><sec><title>Results and discussion</title><p>In marked contrast to previous findings, no polymorphic alleles (neither thymine at position 40 nor cytosine at position 1,400) were detected in any of the individuals tested. This was surprising because both positions were highly polymorphic in the original publications. In those publications, heterozygosity at position 40 (V14M) was detected in four individuals (4.4%) in a small cohort of 91 healthy controls and even in 15 out of 96 (15.6%) lupus patients [<xref ref-type="bibr" rid="B7">7</xref>], and heterozygosity at position 1,400 (L467P) was detected in four individuals (6.7%) in a cohort of 89 allergic patients, although it was absent in healthy controls [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>To verify our results for position 1,400, therefore, we additionally analyzed genomic DNA of 82 well-characterized atopic patients with an established clinically relevant type I allergy directed, for example, to house dust, mite, birch pollen or bee venom. However, this population was not polymorphic at either of the two positions either. Our data therefore strongly suggest that the <italic>IFNG1R </italic>gene is not polymorphic at those two positions at least among Caucasians and therefore does not contribute to genetic susceptibility to RA.</p><p>Some ethnic variations in the frequencies of SNPs linked to RA have been already reported [<xref ref-type="bibr" rid="B8">8</xref>]. Analysis of RA-associated SNPs in solute carrier family 22 members 4 and 5 (<italic>SLC22A4 </italic>and <italic>SLC22A5</italic>) [<xref ref-type="bibr" rid="B9">9</xref>] and in protein tyrosine phosphatase (<italic>PTPN22</italic>) [<xref ref-type="bibr" rid="B10">10</xref>] in different ethnic groups revealed that the disease-associated polymorphic alleles usually common in Caucasians (over 8% prevalence) are absent or only extremely rarely present in the Japanese population [<xref ref-type="bibr" rid="B8">8</xref>]. Our data are in line with these observations and together implicate that association findings should be carefully analyzed in different ethnic contexts to allow meaningful conclusions regarding whether the gene of interest is of importance in the susceptibility to a particular autoimmune disease.</p></sec><sec><title>Conclusion</title><p><italic>IFNGR1 </italic>is not polymorphic in Caucasians although it is polymorphic in the Japanese population. It is therefore unlikely to contribute to susceptibility to RA, at least in Caucasian cohorts of patients.</p></sec><sec><title>Abbreviations</title><p>IFN&#x003b3; = interferon gamma; IFN&#x003b3;R = interferon gamma receptor; PCR = polymerase chain reaction; RA = rheumatoid arthritis; SNP = single nucleotide polymorphism; Th = T helper type.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>SM performed the experiments. AS participated in the design of the study and wrote the manuscript. JRK and PEL participated in the design of the study. HS-K participated in the design of the study and helped to draft the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors thank Dr Florian Schuch, Dr R&#x000fc;diger de la Camp and Dr Mathias Gr&#x000fc;nke for recruiting patients for the study. This work was supported by the Dr Robert Pfleger Foundation, the Deutsche Forschungsgemeinschaft (Grants Schu 786/2-3 and 2-4), the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg (Project B27), and the German Ministry for Education and Research (BMBF 01GI9948, Network for Competence Rheumatology, Project C2-5 and B-3.2).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skapenko</surname><given-names>A</given-names></name><name><surname>Leipe</surname><given-names>J</given-names></name><name><surname>Lipsky</surname><given-names>PE</given-names></name><name><surname>Schulze-Koops</surname><given-names>H</given-names></name></person-group><article-title>The role of the T cell in autoimmune inflammation</article-title><source>Arthritis Res Ther</source><year>2005</year><volume>7</volume><issue>Suppl 2</issue><fpage>S4</fpage><lpage>S14</lpage><pub-id pub-id-type="pmid">15833146</pub-id><pub-id pub-id-type="doi">10.1186/ar1703</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>M</given-names></name><name><surname>Matsui</surname><given-names>E</given-names></name><name><surname>Kaneko</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>R</given-names></name><name><surname>Fukao</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Teramoto</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>Z</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><etal></etal></person-group><article-title>A novel single-nucleotide substitution, Leu 467 Pro, in the interferon-gamma receptor 1 gene associated with allergic diseases</article-title><source>Int J Mol Med</source><year>2003</year><volume>12</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">12851715</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Hisano</surname><given-names>C</given-names></name><name><surname>Kohsaka</surname><given-names>T</given-names></name><name><surname>Nemoto</surname><given-names>Y</given-names></name><name><surname>Niiro</surname><given-names>H</given-names></name><name><surname>Otsuka</surname><given-names>T</given-names></name><name><surname>Otsuka</surname><given-names>T</given-names></name><name><surname>Imamura</surname><given-names>T</given-names></name><name><surname>Niho</surname><given-names>Y</given-names></name></person-group><article-title>Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus</article-title><source>Immunogenetics</source><year>1999</year><volume>49</volume><fpage>266</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">10079289</pub-id><pub-id pub-id-type="doi">10.1007/s002510050492</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aho</surname><given-names>K</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Tuominen</surname><given-names>J</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name></person-group><article-title>Occurrence of rheumatoid arthritis in a nationwide series of twins</article-title><source>J Rheumatol</source><year>1986</year><volume>13</volume><fpage>899</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">3820198</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silman</surname><given-names>AJ</given-names></name><name><surname>MacGregor</surname><given-names>AJ</given-names></name><name><surname>Thomson</surname><given-names>W</given-names></name><name><surname>Holligan</surname><given-names>S</given-names></name><name><surname>Carthy</surname><given-names>D</given-names></name><name><surname>Farhan</surname><given-names>A</given-names></name><name><surname>Ollier</surname><given-names>WE</given-names></name></person-group><article-title>Twin concordance rates for rheumatoid arthritis: results from a nationwide study</article-title><source>Br J Rheumatol</source><year>1993</year><volume>32</volume><fpage>903</fpage><lpage>907</lpage><pub-id pub-id-type="pmid">8402000</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deighton</surname><given-names>CM</given-names></name><name><surname>Walker</surname><given-names>DJ</given-names></name></person-group><article-title>The familial nature of rheumatoid arthritis</article-title><source>Ann Rheum Dis</source><year>1991</year><volume>50</volume><fpage>62</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">1994873</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Akahoshi</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Yamaoka</surname><given-names>K</given-names></name><name><surname>Ogami</surname><given-names>E</given-names></name><name><surname>Nagano</surname><given-names>S</given-names></name><name><surname>Arinobu</surname><given-names>Y</given-names></name><name><surname>Niiro</surname><given-names>H</given-names></name><name><surname>Otsuka</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus</article-title><source>FEBS Lett</source><year>1999</year><volume>453</volume><fpage>187</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">10403400</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(99)00701-2</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>R</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Kawaida</surname><given-names>R</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name></person-group><article-title>Ethnic differences in allele frequency of autoimmune-disease-associated SNPs</article-title><source>J Hum Genet</source><year>2005</year><volume>50</volume><fpage>264</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">15883854</pub-id><pub-id pub-id-type="doi">10.1007/s10038-005-0246-8</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokuhiro</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Kochi</surname><given-names>Y</given-names></name><name><surname>Sawada</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Nagasaki</surname><given-names>M</given-names></name><name><surname>Ohtsuki</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis</article-title><source>Nat Genet</source><year>2003</year><volume>35</volume><fpage>341</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">14608356</pub-id><pub-id pub-id-type="doi">10.1038/ng1267</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Begovich</surname><given-names>AB</given-names></name><name><surname>Carlton</surname><given-names>VE</given-names></name><name><surname>Honigberg</surname><given-names>LA</given-names></name><name><surname>Schrodi</surname><given-names>SJ</given-names></name><name><surname>Chokkalingam</surname><given-names>AP</given-names></name><name><surname>Alexander</surname><given-names>HC</given-names></name><name><surname>Ardlie</surname><given-names>KG</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Spoerke</surname><given-names>JM</given-names></name><etal></etal></person-group><article-title>A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">15208781</pub-id><pub-id pub-id-type="doi">10.1086/422827</pub-id></citation></ref></ref-list></back></article> 